Clonazepam Tablet
Product Images NDC 71335-1843

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 71335-1843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Clonazepam. (Clonazepam 1)

Structural Formula For Clonazepam. (Clonazepam 1)
Chemical structure of the active ingredient clonazepam, displayed as a line drawing with labeled atoms including nitrogen, oxygen, chlorine, and hydrogen within a fused ring system.*
FDA Label Image

Label (Lbl713351843)

Label (Lbl713351843)
Clonazepam 1 mg tablet packaging label by Bryant Ranch Prepack, Burbank, CA. The label states the product is a Schedule IV drug and compares to Klonopin 1 mg tablets by Prinston Laboratories. It includes storage instructions at 20°-25°C (68°-77°F) and a warning that the drug may cause drowsiness. The package contains 20 tablets and displays the NDC 71335-1843-1 with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.